Results 81 to 90 of about 26,501 (228)

Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong? [PDF]

open access: yes, 2013
PurposeTo compare the rates of hepatotoxicity after transarterial chemoembolization for hepatocellular carcinoma (HCC) in patients with and without a transjugular intrahepatic portosystemic shunt (TIPS) who were stratified into comparable risk groups ...
Kohi, Maureen P   +5 more
core   +1 more source

Transarterial chemoembolization in a patient with severe reactions to iodinated contrast: Successful treatment using gadolinium contrast with C-arm computed tomography

open access: yesRadiology Case Reports, 2019
Severe reactions to modern iodinated contrasts are uncommon. Breakthrough reactions in the setting of pretreatment with corticosteroids are even rarer.
Robert Pugh, MS   +3 more
doaj   +1 more source

Rapid Intrasegmental Progression After Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma: Incidence, Imaging Features, and Clinical Outcomes

open access: yesHepatology Research, EarlyView.
ABSTRACT Aim Radiofrequency ablation (RFA) is curative therapy for early‐stage hepatocellular carcinoma (HCC), but a rare subset of patients develop aggressive intrasegmental recurrence shortly after complete ablation. We characterized the incidence, risk factors, and absolute risk.
Takuma Kaneko   +8 more
wiley   +1 more source

Doege-Potter syndrome presenting with hypoinsulinemic hypoglycemia in a patient with a malignant extrapleural solitary fibrous tumor: a case report

open access: yesJournal of Medical Case Reports, 2013
Introduction Doege-Potter syndrome is a paraneoplastic syndrome characterized by non-islet cell tumor hypoglycemia secondary to a solitary fibrous tumor.
Schutt Robert C   +6 more
doaj   +1 more source

Atezolizumab Plus Bevacizumab Treatment for Patients With Hepatocellular Carcinoma in the Barcelona Clinic Liver Cancer B2 Stage

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aim The optimal treatment strategy for patients with intermediate‐stage hepatocellular carcinoma beyond the up‐to‐seven criteria (Barcelona Clinic Liver Cancer B2) remains uncertain. Although transarterial chemoembolization has long been the standard of care, its efficacy is limited in this subgroup, and systemic therapies have ...
Keishi Ouchi   +22 more
wiley   +1 more source

Transarterial Chemoembolization in a Woodchuck Model of Hepatocellular Carcinoma

open access: yesJournal of Vascular and Interventional Radiology, 2020
To assess the feasibility of transarterial chemoembolization with drug-eluting embolic (DEE) microspheres in a woodchuck model of hepatocellular carcinoma (HCC).Nine woodchucks were studied: 4 normal animals and 5 animals infected with woodchuck hepatitis virus in which HCC had developed. Three animals with HCC underwent multidetector CT.
William F, Pritchard   +11 more
openaire   +3 more sources

Staged caval occlusion enabling en bloc right divisional hepatectomy in two dogs with hepatocellular carcinoma

open access: yesVeterinary Surgery, EarlyView.
Abstract Objective To describe staged pre‐renal caudal vena cava (CVC) occlusion before en bloc right divisional hepatectomy with segmental caval resection in two dogs with right divisional hepatocellular carcinoma (HCC) involving the CVC. Animals Two client‐owned, 11‐year‐old neutered male dogs (Siberian Husky and Shih Tzu).
Kumiko Ishigaki, Kazushi Asano
wiley   +1 more source

Missed Diagnosis in Alcohol‐Related Hepatocellular Carcinoma: A Call for Alcohol Consumption and Liver Disease Early Detection

open access: yesLiver International, Volume 46, Issue 11, November 2026.
ABSTRACT Alcohol‐related hepatocellular carcinoma is an increasingly prevalent consequence of alcohol use and the often‐silent progression of alcohol‐related liver disease. A substantial proportion of patients with alcohol‐related hepatocellular carcinoma are diagnosed at an advanced stage, frequently because underlying liver disease has not been ...
Victoria Mignot   +3 more
wiley   +1 more source

Drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma: does size really matter? [PDF]

open access: yes, 2020
PURPOSEWe aimed to compare the safety and effectiveness of 100–300 μm versus 300–500 μm drug-eluting bead transarterial chemoembolization (DEB-TACE) and to investigate the impact of tumor and feeding artery size on treatment outcome of different particle
Sieh-Yang Lee   +5 more
core   +1 more source

Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia

open access: yesAmerican Journal of Hematology, Volume 101, Issue 10, Page 2571-2580, October 2026.
ABSTRACT Chronic liver disease (CLD)‐related thrombocytopenia can limit the feasibility of invasive procedures. Recombinant human thrombopoietin (rhTPO) has demonstrated a favorable safety profile without hepatotoxicity. We evaluated the efficacy and safety of rhTPO in patients with CLD‐related thrombocytopenia who were undergoing elective invasive ...
Yifan Han   +45 more
wiley   +1 more source

Home - About - Disclaimer - Privacy